VREX Varex Imaging Corp.: Market Capitalization to Book Value Ratio

Varex Imaging Corporation (VREX) - corporate logo

Varex Imaging (VREX) production is complicated by US export restrictions and logistical disruptions, which are hindering electronics deliveries and the overseas sale of systems. The price action, which has reached 1.57, aligns with data regarding plants in Asia, Europe, and the US that ensure the production of key components. Its status as a primary B2B partner for medical holdings and deep integration into client devices protect the business from cheap alternatives and price wars.

VREX (Varex Imaging Corp.) Market Capitalization to Book Value history from 07/04/2022 to 10/28/2026
Product sample of Varex

This ratio measures the gap between the market value of Varex Imaging (VREX) and its net assets, determining the extent of the premium or discount to equity. By analyzing the trend of the market-to-book ratio, an investor can see how diversification between medical technology and cargo security stabilizes the company's valuation, shielding it from single-sector volatility and confirming the fundamental resilience of the business.

Direct competitors

Market Cap to Net Assets Ratio Abbott Laboratories|thermofisher.com (TMO) - Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio GE HealthCare Technologies (GEHC)|Capitalization to Book Value Ratio Mettler-Toledo|WAT (Waters Corp.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Bio-Techne Inc. (TECH)|Market Capitalization to Book Value Ratio BRKR (Bruker Corporation)|Market Capitalization to Book Value Ratio azenta.com AZTA|Market Capitalization to Book Value Ratio SMLR|BFLY: Market Value to Equity Ratio|Market Value to Book Value Ratio Mesa Labs Corp|QSI (Quantum-Si Corporation) - Capitalization to Book Value Ratio|Market Value to Book Value Ratio NNOX (Nano-X Imaging Ltd.)|Market-to-Book Ratio QTRX|MASS (908 Devices) - Market Value to Book Value Ratio|Market Capitalization to Book Value capsovision.com CV|Market Cap to Net Assets Ratio MaxCyte, Inc (MXCT)|Market Cap to Book Value Multiple Rapid Micro Biosystems Inc. RPID|Market Capitalization to Book Value Ratio SEER (Seer, Inc.)|HYPR - Market Capitalization to Book Value|FONR (FONAR) - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Daxor|MDAI - Market Cap to Net Assets Ratio|Market Value to Book Value VIVS|Market Value to Book Value Ratio ACON (Aclarion)|Market Cap to Net Assets Ratio akoyabio.com (AKYA)|THMO: Market Capitalization to Book Value Ratio|Market-to-Book Ratio Talis Biomedical Corp. TLIS|T2 Biosystems, Inc (TTOO) - Market Capitalization to Book Value Ratio